Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Oncogenic alterations in advanced NSCLC: a molecular super-highway
Friedlaender, Alex, Perol, Maurice, Banna, Giuseppe Luigi, Parikh, Kaushal, Addeo, Alfredo
Published in Biomarker research (12.02.2024)
Published in Biomarker research (12.02.2024)
Get full text
Journal Article
Safety, Clinical Activity, and Pharmacokinetics of Alflutinib (AST2818) in Patients With Advanced NSCLC With EGFR T790M Mutation
Shi, Yuankai, Zhang, Shucai, Hu, Xingsheng, Feng, Jifeng, Ma, Zhiyong, Zhou, Jianying, Yang, Nong, Wu, Lin, Liao, Wangjun, Zhong, Dafang, Han, Xiaohong, Wang, Ziping, Zhang, Xiaodong, Qin, Shukui, Ying, Kejing, Feng, Jian, Fang, Jian, Liu, Li, Jiang, Yong
Published in Journal of thoracic oncology (01.06.2020)
Published in Journal of thoracic oncology (01.06.2020)
Get full text
Journal Article
Digital Versus Manual PD-L1 Scoring in Advanced NSCLC From the IMpower110 and IMpower150 Trials
Herbst, Roy S., Prizant, Hen, Ruderman, Daniel, Conway, Jake, Shamshoian, John, Koeppen, Hartmut, Zou, Wei, de Marinis, Filippo, Giaccone, Giuseppe, Jassem, Jacek, Spigel, David R., Socinski, Mark A., Reck, Martin, Molinero, Luciana, Ballinger, Marcus, Shames, David, Griffin, Michael, Yu, Limin, Agrawal, Nishant, Beck, Andrew, Wapinski, Ilan, Hennek, Stephanie, Giltnane, Jennifer, Srivastava, Minu K.
Published in Journal of thoracic oncology (05.08.2025)
Published in Journal of thoracic oncology (05.08.2025)
Get full text
Journal Article
Investigating efficacy of “microbiota modulation of the gut-lung Axis” combined with chemotherapy in patients with advanced NSCLC: study protocol for a multicenter, prospective, double blind, placebo controlled, randomized trial
Xia, Qing, Chen, Guojie, Ren, Yanbei, Zheng, Tiansheng, Shen, Changxing, Li, Ming, Chen, Xiangyun, Zhai, Hong, Li, Zhuang, Xu, Jianfang, Gu, Aiqin, Jin, Meiling, Fan, Lihong
Published in BMC cancer (22.06.2021)
Published in BMC cancer (22.06.2021)
Get full text
Journal Article
Role of aneuploid circulating tumor cells and CD31+ circulating tumor endothelial cells in predicting and monitoring anti‐angiogenic therapy efficacy in advanced NSCLC
Zhang, Tongmei, Zhang, Lina, Gao, Yuan, Wang, Ying, Liu, Yanxia, Zhang, Hongmei, Wang, Qunhui, Hu, Fanbin, Li, Jie, Tan, Jinjing, Wang, Daisy Dandan, Gires, Olivier, Lin, Peter Ping, Li, Baolan
Published in Molecular Oncology (01.11.2021)
Published in Molecular Oncology (01.11.2021)
Get full text
Journal Article
The Selective Personalized Radio-immunotherapy for Locally Advanced NSCLC Trial (SPRINT): Initial results
Ohri, Nitin, Jolly, Shruti, Cooper, Benjamin T., Kabarriti, Rafi, Bodner, William Raymond, Klein, Jonathan, Viswanathan, Shankar, Shum, Elaine, Sabari, Joshua K., Cheng, Haiying, Gucalp, Rasim A., Castellucci, Enrico, Qin, Angel, Gadgeel, Shirish M., Halmos, Balazs
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Immune Checkpoint Blockade for Advanced NSCLC: A New Landscape for Elderly Patients
Perrotta, Fabio, Rocco, Danilo, Vitiello, Fabiana, De Palma, Raffaele, Guerra, Germano, De Luca, Antonio, Navani, Neal, Bianco, Andrea
Published in International journal of molecular sciences (07.05.2019)
Published in International journal of molecular sciences (07.05.2019)
Get full text
Journal Article
The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial (SPRINT)
Ohri, N., Jolly, S., Cooper, B.T., Kabarriti, R., III, W. R. Bodner, Klein, J., Viswanathan, S., Kaufman, R., Shum, E., Sabari, J.K., Cheng, H., Gucalp, R., Castellucci, E., Qin, A., Gadgeel, S.M., Halmos, B.
Published in International journal of radiation oncology, biology, physics (01.11.2022)
Published in International journal of radiation oncology, biology, physics (01.11.2022)
Get full text
Journal Article
Predictive implications of immune-related adverse events after exposure to VEGF inhibitors on outcomes in patients with advanced NSCLC treated with prior immune check point inhibitor
Kim, Jinah, Merker, Ami, Caprino, Jessie, Rehman, Hibba tul
Published in Journal of clinical oncology (01.06.2025)
Published in Journal of clinical oncology (01.06.2025)
Get full text
Journal Article
Update to role of the neutrophil lymphocyte ratio in patients with advanced NSCLC undergoing immunotherapy
Richardet, Eduardo, Acosta, Luciana Paola, Magi, Ignacio, tello Alfonso, Rocio, Peruchin, Rita Vanessa, Perea, Pablo, Molina, Matias, Richardet, Martin
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Pembrolizumab as first-line treatment for advanced NSCLC in older adults: A phase II clinical trial evaluating geriatric and quality-of-life outcomes
Blanco, Remei, Dómine, Manuel, González, José Luis, Loutfi, Sami, Alfaro, Jordi, Saldaña, Juana, Rubio, Jaime, Campos, Begoña, Hidalgo, Julia, Barba, Andrés, Márquez, Diego, Martin, Maria, Olaverri, Amaya, Nadal, Ernest
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2023)
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2023)
Get full text
Journal Article
Multi-center real-world data curation and assessment of tumor growth rate and overall survival in advanced NSCLC treated with PD-(L)1 immune checkpoint inhibitor therapy
Jordan, Petr, McCall, Ross, Patel, Arpan, Owen, Dwight Hall, Amini, Arya, Liu, An, Curti, Brendan D., Weerasinghe, Roshanthi K., Lee, Soohee, Page, Ray D., Swalduz, Aurélie, Beregi, Jean-Paul, Sanchez, Stéphane, Gevaert, Olivier, Parikh, Ravi Bharat, Simon, George R., Aerts, Hugo
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
SWATH™- and iTRAQ-based quantitative proteomic analyses reveal an overexpression and biological relevance of CD109 in advanced NSCLC
Zhang, Fanglin, Lin, Hechun, Gu, Aiqin, Li, Jing, Liu, Lei, Yu, Tao, Cui, Yongqi, Deng, Wei, Yan, Mingxia, Li, Jinjun, Yao, Ming
Published in Journal of proteomics (06.05.2014)
Published in Journal of proteomics (06.05.2014)
Get full text
Journal Article
RAGE Genetic Polymorphisms Are Associated with Risk, Chemotherapy Response and Prognosis in Patients with Advanced NSCLC
Wang, Xiang, Cui, Enhai, Zeng, Huazong, Hua, Feng, Wang, Bin, Mao, Wei, Feng, Xueren
Published in PloS one (05.10.2012)
Published in PloS one (05.10.2012)
Get full text
Journal Article
Relationship between PLR and Clinicopathological Characteristics of Patients with Advanced NSCLC and Its Predictive Value for the Efficacy of Chemotherapy and Prognosis
Zhao, Jianming, Pan, Yiping, Sheng, Yu, Sun, Jun
Published in Emergency medicine international (30.09.2022)
Published in Emergency medicine international (30.09.2022)
Get full text
Journal Article
Abstract CT191: Interim results from CLASSICAL-Lung, phase 1b/2 study of pepinemab (VX15/2503) in combination with avelumab in advanced NSCLC
Goldman, Jonathan W., Fisher, Terrence L., Evans, Elizabeth, Leonard, John E., Pastore, Desa Rae, Mallow, Crystal, Smith, Ernest, Schröeder, Andreas, Chin, Kevin, Shafique, Michael, Beck, Thaddeus, Baumgart, Megan A., Govindan, Ramaswamy, Gabrail, Nashat, Sanborn, Rachel E., Spira, Alexander I., Seetharamu, Nagashree, Lou, Yanyan, Mansfield, Aaron S., Zauderer, Maurice
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article